Madison Area Lyme Support Group

Like so many other pioneers who expose inconvenient truths about Lyme, the Michigan State Attorney’s Office told Dr. Lida Mattman to stop testing for Lyme using her gold standard direct culture technique.  She also successfully duplicated the results of the Bowen Q-RiBb test, which provided a preliminary report of the findings within 24 hours of receiving the specimen. The final report included digital photographs of the finding, which was useful in evaluating treatment by comparing pre and post serial dilution results.

Direct testing for Lyme has been attacked for over 20 years.  The CDC has persecuted any test they don’t have control over and get kick backs from.

Mattman was subsequently threatened with time in jail or a fine of 5,000 dollars a day.  State police arrived at her lab with handcuffs and tried to find evidence that she was still testing but they didn’t find what they were looking for. She was forced to stop her valuable work and leave her lab.

The continued adherence to worthless 2-tier CDC testing is on purpose.  They don’t want an accurate test – they’ve had two already and buried them!

I question the use of PCR for diagnosing anything.  Just look at the COVID fiasco due to faulty testing.  Time will tell on this new IGeneX test.

For more:

• https://madisonarealymesupportgroup.com/2018/09/12/lyme-testing-problems-solutions/
• https://madisonarealymesupportgroup.com/2023/10/05/yet-another-study-showing-lyme-testing-sucks-how-many-more-do-we-need/
• https://madisonarealymesupportgroup.com/2020/11/05/your-lyme-disease-test-results-are-negative-but-your-symptoms-say-otherwise/
• https://madisonarealymesupportgroup.com/2025/05/16/why-doctor-treated-patient-for-lyme-even-when-his-test-was-negative/
• https://madisonarealymesupportgroup.com/2019/03/30/new-comprehensive-testing-for-vector-borne-disease-medical-diagnostic-labs/

Despite having nearly every symptom and being ER bound, neither my husband nor I managed to test positively on the CDC’s 2-tiered testing which sets arbitrary limits and omits the most specific band that is sometimes the only marker for those with late-stage Lyme due to decision made in Dearborn, Michigan decades ago.

The most divisive part of the two-step diagnostic standard – now called the Dearborn criteria – was elimination from the Western blot of two Bb proteins, outer surface protein A (OspA), from which LYMErix was made, and outer surface protein B (OspB), the intended component of next-generation vaccines.  Source